Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Clin Immunol ; 44(2): 56, 2024 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-38277122

RESUMEN

Varicella zoster virus (VZV) is a neurotropic alphaherpesvirus exclusively infecting humans, causing two distinct pathologies: varicella (chickenpox) upon primary infection and herpes zoster (shingles) following reactivation. In susceptible individuals, VZV can give rise to more severe clinical manifestations, including disseminated infection, pneumonitis, encephalitis, and vasculopathy with stroke. Here, we describe a 3-year-old boy in whom varicella followed a complicated course with thrombocytopenia, hemorrhagic and necrotic lesions, pneumonitis, and intermittent encephalopathy. Hemophagocytic lymphohistiocytosis (HLH) was strongly suspected and as the condition deteriorated, HLH therapy was initiated. Although the clinical condition improved, longstanding hemophagocytosis followed despite therapy. We found that the patient carries a rare monoallelic variant in autocrine motility factor receptor (AMFR), encoding a ubiquitin ligase involved in innate cytosolic DNA sensing and interferon (IFN) production through the cyclic GMP-AMP synthase-stimulator of IFN genes (cGAS-STING) pathway. Peripheral blood mononuclear cells (PBMCs) from the patient exhibited impaired signaling downstream of STING in response dsDNA and 2'3'-cGAMP, agonists of cGAS and STING, respectively, and fibroblasts from the patient showed impaired type I IFN responses and significantly increased VZV replication. Overexpression of the variant AMFR R594C resulted in decreased K27-linked STING ubiquitination compared to WT AMFR. Moreover, ImageStream technology revealed reduced STING trafficking from ER to Golgi in cells expressing the patient AMFR R594C variant. This was supported by a dose-dependent dominant negative effect of expression of the patient AMFR variant as measured by IFN-ß reporter gene assay. Finally, lentiviral transduction with WT AMFR partially reconstituted 2'3'-cGAMP-induced STING-mediated signaling and ISG expression in patient PBMCs. This work links defective AMFR-STING signaling to severe VZV disease and hyperinflammation and suggests a direct role for cGAS-STING in the control of viral infections in humans. In conclusion, we describe a novel genetic etiology of severe VZV disease in childhood, also representing the first inborn error of immunity related to a defect in the cGAS-STING pathway.


Asunto(s)
Varicela , Herpes Zóster , Interferón Tipo I , Linfohistiocitosis Hemofagocítica , Neumonía , Preescolar , Humanos , Herpesvirus Humano 3/genética , Inmunidad Innata , Leucocitos Mononucleares/metabolismo , Linfohistiocitosis Hemofagocítica/diagnóstico , Linfohistiocitosis Hemofagocítica/genética , Nucleotidiltransferasas/genética , Nucleotidiltransferasas/metabolismo , Receptores del Factor Autocrino de Motilidad , Ubiquitina-Proteína Ligasas/genética , Masculino
2.
J Infect Dis ; 225(1): 157-162, 2022 01 05.
Artículo en Inglés | MEDLINE | ID: mdl-34037797

RESUMEN

The present study describes a 19-year-old woman with systemic herpes simplex virus (HSV)-1 infection and hemophagocytic lymphohistiocytosis (HLH) postpartum, and a fatal course of neonatal herpesvirus infection. Functional investigation of cells from the mother demonstrated significantly impaired induction of antiviral interferons and cytokines in the context of normal activation of the transcription factors NF-κB and IRF3. Whole-exome sequencing did not reveal any functionally validated genetic variants. We suggest that the functionally impaired antiviral responses, potentially caused by a variant in CASP8 or other variants in noncoding regions of the genome, contributed to the unusually severe disease course observed in two generations.


Asunto(s)
Herpes Simple/diagnóstico , Herpesvirus Humano 1/aislamiento & purificación , Linfohistiocitosis Hemofagocítica/complicaciones , Antivirales/uso terapéutico , Enfermedades Transmisibles/tratamiento farmacológico , Citocinas , Femenino , Herpes Simple/complicaciones , Herpes Simple/tratamiento farmacológico , Herpes Simple/mortalidad , Herpesvirus Humano 1/genética , Humanos , Inmunidad Innata , Transmisión Vertical de Enfermedad Infecciosa , Interferones/uso terapéutico , Linfohistiocitosis Hemofagocítica/tratamiento farmacológico , Periodo Posparto , Complicaciones Infecciosas del Embarazo , Secuenciación del Exoma , Adulto Joven
3.
Autophagy ; 17(9): 2449-2464, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-33016799

RESUMEN

Paralytic poliomyelitis is a rare disease manifestation following poliovirus (PV) infection. The disease determinants remain largely unknown. We used whole exome sequencing to uncover possible contributions of host genetics to the development of disease outcome in humans with poliomyelitis. We identified a patient with a variant in ATG7, an important regulatory gene in the macroautophagy/autophagy pathway. PV infection did not induce a prominent type I interferon response, but rather activated autophagy in neuronal-like cells, and this was essential for viral control. Importantly, virus-induced autophagy was impaired in patient fibroblasts and associated with increased viral burden and enhanced cell death following infection. Lack of ATG7 prevented control of infection in neuronal-like cells, and reconstitution of patient cells with wild-type ATG7 reestablished autophagy-mediated control of infection. Collectively, these data suggest that ATG7 defect contributes to host susceptibility to PV infection and propose autophagy as an unappreciated antiviral effector in viral infection in humans.


Asunto(s)
Interferón Tipo I , Poliomielitis , Poliovirus , Autofagia/genética , Proteína 7 Relacionada con la Autofagia/genética , Humanos , Neuronas , Poliomielitis/genética , Poliomielitis/prevención & control , Poliovirus/genética
4.
Front Immunol ; 11: 1606, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32695122

RESUMEN

Coronavirus disease-19 (COVID-19) describes a set of symptoms that develop following infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Whilst COVID-19 disease is most serious in patients with significant co-morbidities, the reason for healthy individuals succumbing to fulminant infection is largely unexplained. In this review, we discuss the most recent findings in terms of clinical features and the host immune response, and suggest candidate immune pathways that may be compromised in otherwise healthy individuals with fulminating COVID-19. On the basis of this early knowledge we reason a potential genetic effect on host immune response pathways leading to increased susceptibility to SARS-CoV-2 infection. Understanding these pathways may help not only in unraveling disease pathogenesis, but also in suggesting targets for therapy and prophylaxis. Importantly such insight should instruct efforts to identify those at increased risk in order to institute preventative measures, such as prophylactic medication and/or vaccination, when such opportunities arise in the later phases of the current pandemic or during future similar pandemics.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Predisposición Genética a la Enfermedad , Pandemias , Neumonía Viral , Betacoronavirus/genética , Betacoronavirus/inmunología , COVID-19 , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/genética , Infecciones por Coronavirus/inmunología , Humanos , Neumonía Viral/epidemiología , Neumonía Viral/genética , Neumonía Viral/inmunología , SARS-CoV-2 , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...